Evidence has suggested that these proteins are active in inflammatory and autoimmune disease by activating the nuclear factor kappa B (NF-κB) signaling [51], which suggests a role in patients with BCRL or at risk [52]. The gene discussed is NFKB1; the disease is autoimmune disease.